Home Cart Sign in  
Chemical Structure| 225110-25-8 Chemical Structure| 225110-25-8

Structure of (+)-(3R,8S)-Falcarindiol
CAS No.: 225110-25-8

Chemical Structure| 225110-25-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(+)-(3R,8S)-Falcarindiol, a natural product isolated and purified from the roots of Angelica sinensis, is a potential anticancer agent that exerts its activity through inducing ER stress and apoptosis, and induces immunosuppressive effects in vitro and in vivo and might be a therapy for autoimmune or allergic diseases.

Synonyms: 3(R),8(S),9(Z)-Falcarindiol; Falcarindiol; (3R,8S)-Falcarindiol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (+)-(3R,8S)-Falcarindiol

CAS No. :225110-25-8
Formula : C17H24O2
M.W : 260.37
SMILES Code : C=C[C@@H](O)C#CC#C[C@@H](O)/C=C\CCCCCCC
Synonyms :
3(R),8(S),9(Z)-Falcarindiol; Falcarindiol; (3R,8S)-Falcarindiol
MDL No. :N/A
InChI Key :QWCNQXNAFCBLLV-YWALDVPYSA-N
Pubchem ID :5281148

Safety of (+)-(3R,8S)-Falcarindiol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • JNK

In Vitro:

Cell Line
Concentration Treated Time Description References
J774.1 25-100 µM 24 h FAD reduces LPS-induced pro-inflammatory cytokines. PMC11727077
Raw264.7 25-100 µM 24 h FAD reduces LPS-induced pro-inflammatory cytokines. PMC11727077
IEC-6 cells 20 μM 48 h Evaluate the safety of Falcarindiol on normal intestinal cells, results showed no significant inhibition on IEC-6 cells at 20 μM PMC3729876
MCF-7 cells 10 μM 48 h Evaluate the antiproliferative effects of Falcarindiol, results showed antiproliferative effects on MCF-7 cells at 10 μM PMC3729876
SW-480 cells 10 μM 48 h Evaluate the antiproliferative effects of Falcarindiol, results showed significant inhibition of SW-480 cell growth at 10 μM PMC3729876
HCT-116 cells 10 μM 48 h Evaluate the antiproliferative effects of Falcarindiol, results showed almost complete inhibition of HCT-116 cell growth at 10 μM PMC3729876
MCF-7 7.5 µM 24 h FAD induces caspase-3-dependent apoptosis by regulating NOX4 and ER stress signaling pathways. PMC11727077
MDA-MB-231 7.5 µM 24 h FAD induces caspase-3-dependent apoptosis by regulating NOX4 and ER stress signaling pathways. PMC11727077
Rat primary astrocytes 50 μM 30 min To investigate the inhibitory effect of falcarindiol on LPS/IFN-γ-induced iNOS expression. Results showed that falcarindiol attenuated the activation of IKK and JAK, leading to the blockade of NF-κB and Stat1 activation, thereby suppressing iNOS expression. PMC1575975
FHs 74 Int. cells 1 ng/mL to 20 μg/mL 72 h No hormesis effect was observed, and significant inhibition of proliferation was observed at concentrations of 1 μg/mL and above. PMC2745230
Caco-2 cells 1 ng/mL to 20 μg/mL 72 h A hormesis effect was observed, with a 42% increase in cell proliferation at 100 ng/mL. Significant inhibition of proliferation was observed at concentrations of 2.5 μg/mL and above. PMC2745230

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Athymic nude mice HCT-116-Luc xenograft model Intraperitoneal injection 15 mg/kg Once daily for 4 weeks Evaluate the in vivo antitumor effects of Falcarindiol, results showed significant inhibition of HCT-116 tumor growth at 15 mg/kg PMC3729876
BALB/c nude mice MDA-MB-231 xenograft model Intraperitoneal injection 10 or 20 mg/kg Twice weekly FAD reduces tumor volume in a dose-dependent manner. PMC11727077

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.84mL

0.77mL

0.38mL

19.20mL

3.84mL

1.92mL

38.41mL

7.68mL

3.84mL

References

 

Historical Records

Categories